Michele Reni

11PUBLICATIONS
40CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Oral medicine and pathologyPredictive and prognostic markersCancer geneticsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 27, 2026
Management of Patients with Suspected Hypersensitivity to Chemotherapy Drugs: A Practical Approach in a Tertiary Care Setting.

|Feb 20, 2026
Paired Duodenal and Salivary Microbiome Analysis in Pancreatic Cancer Without Duct Obstruction.

Livia Archibugi, Loris Bertoldi, Giuseppe Benvenuto

|May 20, 2025
Anatomically resectable versus biologically borderline resectable pancreatic cancer definition: refining the border beyond anatomical criteria and biological aggressiveness.

Giulio Belfiori, Federico De Stefano, Domenico Tamburrino

|Mar 28, 2025
Temporal Validation of an FDG-PET-Radiomic Model for Distant-Relapse-Free-Survival After Radio-Chemotherapy for Pancreatic Adenocarcinoma.

Monica Maria Vincenzi, Martina Mori, Paolo Passoni

|Jan 25, 2025
Real-World Impact of Olaparib Exposure in Advanced Pancreatic Cancer Patients Harboring Germline BRCA1-2 Pathogenic Variants.

Michele Milella, Giulia Orsi, Mariacristina di Marco

|Sep 19, 2023
Clinical outcomes and response to chemotherapy in a cohort of pancreatic cancer patients with germline variants of unknown significance (VUS) in BRCA1 and BRCA2 genes.

Anna Maria Militello, Giulia Orsi, Alessandro Cavaliere

Pageof 2

Frequent Collaborators

2 joint publications

Sara Lonardi

1 joint publications

Giampaolo Tortora

1 joint publications

Mario Scartozzi

1 joint publications

Ingrid Garajova